Algernon Announces First Patient Dosed in Phase 2 IPF and Chronic Cough Human Trial of Ifenprodil

    NEXT STORY
    AXIM® Biotechnologies Applies for FDA Emergency Use Approval (EUA) for High Throughput, Patent-Pending Neutralizing Antibody Diagnostic Test for COVID-19
    PREV STORY
    Bellerophon Provides Clinical Program Update and Reports Second Quarter 2020 Financial Results
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    MacroGenics to Participate in Two Upcoming Investor Conferences

    Rockville, MD, Feb. 27, 2017 (GLOBE NEWSWIRE) -- -- MacroGenics, Inc. (Nasdaq: MGNX), a ...

    author_avatar
    NASDAQ Market News

    BioTelemetry, Inc. Announces Acquisition of Telcare’s Remote Diabetes Management Platform

    MALVERN, Pa., Dec. 01, 2016 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT), the leading wireless ...

    author_avatar
    NASDAQ Market News

    Recro Pharma Reports First Quarter 2017 Financial Results

    Reports First Quarter 2017 Revenues of $18.7 Million Recently Announced Successful Top-Line Results from ...

    author_avatar
    NASDAQ Market News